Furthermore, IHC analysis demonstrated that tumor tissues derived from anti-miR-130b-3p-expressing cells exhibited much weaker staining for the angiogenic marker CD31 than those in the control counterpart (Fig. 2K). This evidence concerns the gene PECAM1 and neoplasm.